Abstract
Increasing evidence suggests that inflammatory response may be a critical component of different brain pathologies. However, the role played by this reaction is not fully understood. The present findings suggest that neuroinflammtory mediators such as cytokines may be involved in a number of key steps in the pathological cascade of events leading to neuronal injury. This hypothesis is strongly supported by experimental and clinical observations indicating that inhibition of the inflammatory reaction correlates with less neuronal damage. Estrogens are thought to play a role in the sex difference observed in many neurological diseases with inflammatory components including stroke, Alzheimer's and Parkinson's diseases, multiple sclerosis, or amyotrophic lateral sclerosis. Clinical and experimental studies have established estrogen as a neuroprotective hormone in these diseases. However, the exact mechanisms involved in the neuroprotective effects of estrogens are still unclear. It is possible that the beneficial effects of these hormones may be dependent on their inhibitory activity on the inflammatory reaction associated with the above-mentioned brain pathologies. Here, we review the current clinical and experimental evidence with respect to the inflammation-modulating effects of estrogens as one potential explanatory factor for sexual dimorzphism in the prevalence of numerous neurological diseases.
Similar content being viewed by others
References
Benveniste, E. N., Nguyen, V. T., and O'Keefe, G. M. (2001) Neurochem. Int. 39, 381–391.
Kohutnicka, M. Lewandowska, E., Kurkowska-Jastrzebska, I., Czlonkowski, A., and Członkowska, A. (1999) Immunopharmacol. 39, 167–180.
De Simoni, M. G. Milia P., Barba, M., De Luigi, A., Parnetti, L., and Gallai, V. (2002) Clin. Exp. Hypertens. 24, 535–542.
Kurkowska-Jastrzebska, I., Wronska, A., Kohutnicka, M. Czlonkowski, A., and Członkowska, A. (1999) Exp. Neurol. 156, 50–61.
Collawn, J. F. and Benveniste, E. N. (1999). Microbes Infect. 11, 893–902.
Mrak, R. E., and Griffin, W. S. (2005) Neurobiol. Aging 26, 349–354.
Moore, A. H. and O'Banion, M. K. (2002). Adv. Drug Deliv. Rev. 54, 1627–1656.
Bodles, A. M. and Barger, S. W., (2004) Trends Neurosci. 27, 621–626.
Quan N. and Herkenham, M. (2002) Histol. Histopathol. 17, 273–288.
Szelenyi, J. (2001) Brain Res. Bull. 54, 329–338.
Perry, V. H. (2004) Brain Behav. Immun. 18, 407–413.
Marklund, N., Keck, C., Hoover, R., et al. (2005) Restor. Neurol. Neurosci. 23, 31–42.
Hailer, N. P., Vogt, C., Korf, H. W., and Dehghani, F. (2005). Eur. J. Neurosci. 21, 2347–2360.
Gomes-Leal W., Corkill, D. J., Freire, M. A., Picanco-Diniz, C. W., and Perry, V. H. (2004) Exp. Neurol. 190, 456–467.
Craft, J. M., Watterson, D. M., Hirsch, E., and Van Eldik, L. J. (2005). J. Neuroinflammation 2, 15.
Marquardt, L., Ruf, A., Mansmann, U., et al. (2005) J. Neurol. Sci. 15, 65–71.
Grammas, P., and Ovase, R. (2001) Neurobiol. Aging 22, 837–842.
Hirsch, E. C., Hunot, S., and Hartmann, A. (2005). Parkinsonism Relat. Disord. 11 (Suppl. 1), S9-S15.
Silberberg, D. (2001) Mult. Scler. 7, 1.
Al-Shammri, S., Rawoot, P., Azizieh, F., et al. (2004). J. Neurol. Sci. 15, 21–27.
Barbeito, L. H., Pehar, M., Cassina, P., et al. (2004). Brain Res. Brain Res. Rev. 47, 263–274.
Kurkowska-Jastrzebska, I., Litwin, T., Joniec, I., et al. (2004). Int. Immunopharmacol. 4, 1307–1318.
Fahrig, T., Gerlach, I., and Horvath, E. (2005) Mol. Pharmacol. 67, 1544–1555.
Gao, H. M., Liu, B., Zhang, W. and Hong, J. S. (2003) Trends Pharmacol. Sci. 24, 395–401.
Youdim, M. B. and Buccafusco, J. J. (2005) J. Neural. Transm. 112, 519–537.
Lei, D. L., Long, J. M., Hengemihle, J., et al. (2003). Neuroscience 121, 659–666.
Ospina, J. A., Brevig, H. N., Krause, D. N., and Duckles, S. P. (2003) Am. J. Physiol. Heart Circ. Physiol. 286, H2010–2019.
Baker, A. E., Brautigam, V. M., and Watters, J. J. (2004). Endocrinology 145, 5021–5032.
Mor, G., Nilsen, J., Horvath, T., et al. (1999). J. Neurobiol. 40, 484–496.
Wooten, G. F., Currie, L. J., Bovbjerg, V. E., Lee, J. K., and Patrie, J. (2004) J. Neurol. Neurosurg. Psychiatry 75, 637–639.
Beeson, P. B. (1994). Am. J. Med. 96, 457–462.
Hurn, P. and Brass, L. (2003) Stroke 34, 338–343.
Dluzen, D. E. and McDermott, J. L. (2000). J. Gend. Specif. Med. 3, 36–42.
Nordell, V. L., Scarborough, M. M., Buchanan, A. K., and Sohrabji, F. (2003) Neurobiol. Aging 24, 733–743.
Mikkola, T. S. and St Clair, R. W. (2002). Maturitas 41, 313–319.
Suuronen, T., Nuutinen, T., Huuskonen, J., Ojala, J., Thornell, A., and Salminen, A. (2005) Inflamm. Res. 54, 194–203.
Sato, F., Ouchi, Y., Masuyama, A., et al. (1993) Calcif. Tissue Int. 53, 111–116.
Bismar, H., Diel, I., Ziegler, R., and Pfeilschifter, J. (1995) J. Clin. Endocrinol. Metab. 80, 3351–3355.
Cantatore, F. P., Loverro, G., Ingrosso A. M., Lacanna, R., Sassanelli, E., and Selvaggi, L. (1995) Clin. Rheumatol. 14, 157–160.
Liao, S. L., Chen, W. Y., and Chen, C. J. (2002) Neurosci. Lett. 330, 159–162.
Dimayuga, F. O., Reed, J. L., Carnero, G. A., et al. (2005). J. Neuroimmunol. 161, 123–136.
Danel, L., Souweine, G., Monier, J. C., and Saez, S. (1983). J. Steroid. Biochem. 18, 559–563.
Vegeto, E., Belcredito, S., Etteri, S., et al. (2003). Proc. Natl. Acad. Sci. USA 100, 9614–9619.
Liu, X., Fan, X. L., Zhao, Y., et al.. (2005) J. Neurosci. Res. 81, 653–665.
Hall, J. M., and McDonnell, D. P. (1999). Endocrinology 140, 5566–5578.
Beato, M., and Klug, J. (2000) Hum. Reprod. Update 6, 225–236.
Pottratz, S. T., Bellido, T., Mocharla, H., Crabb, D., and Manolagas, S. C. (1994). J. Clin. Invest. 93, 944–950.
Fox, H. S., Bond, B. L., and Parslow, T. G. (1991). J. Immunol. 146, 4362–4367.
Srivastava, S., Weitzmann, M. N., Cenci, S., Ross, F. P., Adler, S., and Pacifici, R. (1999). J. Clin. Invest. 104, 503–513.
Mishra, J. P., Mishra, S., Gee, K., and Kumar, A. (2005). J. Biol. Chem. 280, 26825–26837.
Scott, B. B., Zaratin, P. F., Gilmartin, A. G., et al. (2005). Biochem. Biophys. Res. Commun. 328, 409–414.
An, J., Ribeiro, R. C., Webb, P., Gustafsson, J. A., Kushner, P. J., and Baxter, J. D. (1999) Proc. Natl. Acad. Sci. USA 96, 15161–15166.
Galien, R., and Garcia, T. (1997) Nucleic Acids Res. 25, 2424–2429.
Ghosh, S., May, M. J., and Kopp, E. B. (1998) Annu. Rev. Immunol. 16, 225–260.
Boyce, B. F., Xing, L., Franzoso, G., and Siebenlist, U. (1999). Bone 25, 137–139.
Wen, Y., Yang, S., Liu, R., et al. (2004) Brain Res. 1008, 147–154.
Kalaitzidis, D., and Gilmore, T. D. (2005) Trends Endocrinol. Metab. 16, 46–52.
Quaedackers, M. E., Van Den Brink, C. E., Wissink, S., and Schreurs, R. H. (2001) Endocrinology 142, 1156–1166.
Sun, W. H., Keller, E. T., Stebler, B. S., and Ershler, W. B. (1998) Biochem. Biophys. Res. Commun. 244, 691–695.
Waters, K. M., Rickard, D. J., Riggs, B. L., et al. (2001). J. Cell Biochem. 83, 448–462.
Feldmann, M., Brennan, F. M., and Maini, R. (1996), Cell 85, 307–310.
Sunyer, T., Lewis, J., Collin-Osdoby, P., and Osdoby, P. (1999) J. Clin. Invest. 103, 1409–1418.
Ye, K., Dinarello, C. A. and Clark, B. D. (1993) Proc. Natl. Acad. Sci. USA 90, 2295–2299.
Sims, J. E., Painter, S. L., and Gow, I. R. (1995). Cytokine 7, 483–490.
Zhang, Z., Maier, B., Santen, R. J., and Song, R. X. (2002) Biochem. Biophys. Res. Commun. 294, 926–933.
Bruce-Keller, A. J., Keeling, J. L., Keller, J. N., Huang, F. F., Camondola, S., and Mattson, M. P. (2000) Endocrinology 141, 3646–3656.
Marsden, C. D. and Olanow, C. W. (1998) Ann. Neurol. 44, S189–196.
Currie, L. J., Harrison, M. B., Trugman, J. M., Bennett, J. P., and Wooten, G. F. (2004) Arch. Neurol. 61, 886–888.
Sandyk, R. (1989). Int. J. Neurosci. 45, 119–122.
Saunders-Pullman, R., Gordon-Elliott, J., Parides, M., Fahn, S., Saunders, H. R., and Bressman, S. (1999) Neurology 52, 1417–1421.
Ragonese, P., D'Amelio, M., Salemi, G., et al. (2004) Neurology, 62, 2010–2014.
Brooks, W. J., Jarvis, M. F., and Wagner, G. C. (1989). Res. Commun. Subst. Abuse 10, 181–184.
Dluzen, D. E., McDermott, J. L., and Liu, B. (1996). Neurotoxicol. Teratol. 18, 603–606.
Dluzen, D. E., McDermott, J. L., and Liu, B. (1996). J. Neurochem. 66, 658–666.
Nagatsu, T. (2002). J. Neural. Transm. 109, 731–745.
Nagatsu, T., Mogi, M., Ichinose, H., and Togari, A. (2000). J. Neural. Transm. Suppl. 58, 143–151.
Muller, T., Blum-Degen, D., Przuntek, H., and Kuhn, W. (1998). Acta Neurol. Scand. 98, 142–144.
Hunot, S., Dugas, N., Faucheux, B., et al., (1999). J. Neurosci. 19, 3440–3447.
Chang, J. Y., Martin, D. P., and Johnson, E. M. (1990), J. Neurochem. 55, 436–445.
Hammerberg, H., Lidman, O., Lundberg, C. et al. (2000). J. Neurosci. 20, 5283–5291.
Wandinger, K. P., Hagenah, J. M., Kluter, H., Rothermundt, M., Peters, M., and Vieregge, P. (1999). J. Neuroimmunol. 98, 214–220.
Mizuta, I., Nishimura, M., Mizuta, E., Yamasaki, S., Ohta, M., and Kuno, S. (2001). J. Neurol. Neurosurg. Psychiatry 71, 818–819.
Ciesielska, A., Joniec, I., Przybyłkowski, A., et al. (2003). Acta Neurobiolog. Exp. 63, 117–126.
Mandel, S., Grunblatt, E., and Youdim, M. (2000). J. Neural. Transm. Suppl. 60, 117–124.
Ciesielska, A. and Czlonkowski, A. (2005) Pharmacol. Rep. 57, 4150.
Lawrence, C. B., Allan, S. M., and Rothwell, N. J. (1998) Eur. J. Neurosci. 10, 1188–1195.
Hebert, G., Arsaut, J., Dantzer, R., and Demotes-Mainard, J. (2003), Neurosci. Lett. 349, 191–195.
Bolin, L. M., Strycharska-Orczyk, I., Murray, R., Langston, J. W., and Di Monte, D. (2002). J. Neurochem. 83, 167–175.
Hinkerohe, D., Smikalla, D., Haghikia, A., et al. (2005), Glia 52, 85–97.
Tang, M. X., Jacobs, D., Stern Y., et al. (1996). Lancet 348, 429–432.
Barness, L. L., Wilson, R. S., Bienias, J. J., Schneider, J. A., Evans, D. A., and Bennett, D. A. (2005). Arch. Gen. Psychiatry 62, 685–691.
Kawas, C., Resnick, S., Morrison, A., et al. (1997). Neurology 48, 1517–1521.
Doraiswamy, P. M., Bieber, F., Kaiser, L., et al. (1997). Neurology 48, 1511–1517.
Henderson, A. S., Easteal, S., Jorm, A. F., et al. (1995) Lancet 346, 1387–1390.
Yaffe, K., Sawaya, G., Lieberburg, I., and Grady, D. (1998). JAMA 279, 688–695.
Costa, M. M., Reus, V. I., Wolkowitz, O. M., Manfredi, F., and Lieberman, M., (1999). Biol. Psychiatry 46, 182–188.
Henderson, V. W., Paganini-Hill, A., Miller, B. L., et al. (2000). Neurology 54, 295–301.
Mulnard R. A., Cotman, C. W., Kawas, C., et al., (2000). JAMA 283, 1007–1015.
Craig, M. C., Maki, P. M., and Murphy, D. G. M. (2005), Lancet Neurol. 4, 190–194.
Webber, K. M., Casadesus, G., Marlatt, M. W. et al. (2005). Ann. NY Acad. Sci., 1052, 201–209.
McGeer, E. G. and McGeer, P. L. (1997) Mov. Disord. 12, 855–860.
Mrak, R.E., and Griffinbe, W. S. (2001) Neurobiol. Aging 22, 915–922.
Rothwell, N. (2003). Brain Behav. Immun. 17, 152–157.
Ciallella, J. R., Ikonomovic, M. D., Paljug, W. R., et al. (2002), J. Neurotrauma 19, 1555–1567.
Wang, J., Tanila, H., Puolivali, J., Kadish, I., and Groen, T. (2003). Neurobiol. Dis. 14, 318–327.
Morris, F., Shepherd, R., Denys, E. et al. (1993). J. Neurol. Sci. 118, 48–55.
Ono, S., Hu, J., Shimizu, N., Imai, T., and Nakagawa, H. (2001). J. Neurol. Sci. 187, 27–34.
Sekizawa, T., Openshaw, H., Ohbo, K., Sugamura, K., Itoyama, Y., and Nilan, J. C. (1998). J. Neurol. Sci. 154, 194–199.
Hensley, K., Fedynyshyn, J., Ferrell, S., et al. (2003). Neurobiol. Dis. 14, 74–80.
Xie, Y., Weydt, P., Howland, D. S., Kliot, M., and Moller, T.. (2004). Neuroreport 15, 2513–2516.
Weydt, P., Yuen, E.C., Ransom, B. R., and Moller, T., (2004). Glia 48, 179–182.
Veldink, J. H., Bar, P. R., Joosten, E. A., Otten, M., Wokke, J. H., and van den Berg, L. H. (2003). Neuromuscul. Disord. 13, 737–743.
Trieu, V. N., and Uskun, F. M. (1999). Biochem. Biophys. Res. Commun. 258, 685–688.
Nakamizo, T., Urushitani, M., Inoue, R. et al. (2000). Neuroreport 11, 3493–3497.
Rudnicki, S. A. (1999). J. Neurol. Sci. 169, 126–127.
Runmarker, B., Martinsson, T., Wahlstrom, J., and Andersen, O. (1994). J. Neurol. 241, 385–390.
Hensiek, A., Sawcer, S., Feakes, R., et al. (2002). J. Neurol. Neurosurg. 72, 184–187.
Hensiek, A., Roxburgh, R., Smilie, B., et al. (2003). J. Neuroimmunol. 143, 25–30.
Cedlius, E. G., Harbo, H. F., Egeland, T., Vartal, F., Vandvik, B., and Spurkiand A., (2000). J. Neurol. Sci. 178, 132–135.
Confavreux, C., Hutchinson, M., Heurs, M. M., Cortinivis-Tourniare, P., and Moreau, T. (1998). N. Engl. J. Med. 39, 285–291.
Villard-Mackintosh, L. and Vessey, M. P. (1993). Comtraception 47, 161–168.
Offner, H. (2004). J. Neurosci. Res. 78, 603–624.
Dalal, M., Kim, S., and Voskuhl, R. R. (1997). J. Immunol. 159, 3–6.
Vranckx, R., Muylle, L., Cole, J., Moldenhaser, R., and Peetermans, M. (1986). Vox Sang 50, 220–222.
Amadori, A., Zamarchi, R., De Silvestro, G., et al. (1995). Nat. Med., 1, 1279–1283.
Pelfrey, C. M., Cotleur, A. C., Lee, J. C., and Rudick, R. A. (2002). J. Neuroimmunol. 130, 211–223.
Wilcoxen, S. C., Kirkman, E., Dowdell, K. C., and Stohlman, S. A. (2000). J. Immunol. 164, 6237–6243.
Nguyen, L. T., Ramanathan, M., Weinstock-Guttman, B., Baier, M., Brownscheidle, C., and jacobs, L. D. (2003). J. Neurol. Sci. 209, 93–99.
Mirowska, D., Skierski, J., Paz, A., et al. (2003). J. Neurol. 250, 1229–1236.
Ito, A., Bebo, B. F. Jr., Matejuk, A., et al. (2001), J. Immunol. 1, 542–552.
Matejuk, A., Adlard, K., Zamora, A., Silverman, M., Vandenbark, A. A., and Offner, H. (2001). J. Neurosci. Res. 65, 529–542.
Bonita, R., (1992). Lancet 339, 342–344.
2002 Heart and Stroke Stautistical Update, American Heart Association; http://www.americanheart.org/statistics.
Niewada, M., Kobayashi, A., Sandercock, P. A., Kaminski, B., and Członkowska, A. (2005). Neuroepidemiology 24, 123–138.
Di Carlo, A., Lamassa, M., Baldereschi, M., et al. (2003). Stroke 34, 1114–1119.
Murphy, S. J., McCullough, L. D., and Smith, J. M. (2004). ILAR J. 45, 147–159.
Sudlow, C. L. M. and Warlow, C. P. (1997). Stroke 28, 491–499.
Jerntorp, P., and Berglund, G. (1992). Stroke 23, 357–361.
Ricci, S., Celani, M. G., La Rosa, F., et al. (1991). J. Neurol. Neurosurg. Psychiatry 54, 695–698.
Sacco, R. L., Wolf, P. A., Kannel, W. B., and McNamara, P. M. (1982). Stroke 13, 290–295.
Kannel, W. B., Hjortland, M. C., McNamara, P. M., and Gordon, T. (1976). Ann. Intern. Med. 85, 447–452.
Wolf, P. A. (1990)., Stroke, 21(9 Suppl.), II4–6.
Barker, W. H. and Mullooly, J. P. (1997). Stroke 28, 284–290.
Mikkola, T. S. and Clarkson, T. B. (2002). Cardiovasc. Res. 53, 605–619.
Sader, M. A., and Celermajer, D. S. (2002). Cardiovasc. Res. 53, 597–604.
Cusa, C., and Mazzone, A. (2002). Drugs Today, 38, 699–712.
Young, J. L., Libby, P., and Schonbeck, U. (2002), Thromb. Haemost. 88, 554–567.
Chamorro, A., (2004). Cerebrovasc. Dis. 17 (Suppl. 3), 1–5.
Sukovich, D. A., Kauser, K., Shirley, F. D., DelVecchio, V., Halks-Miller, M., and Rubanyi, G. M. (1998)., Arterioscler. Thromb. Vasc. Biol. 18, 1498–1505.
Elhage, R., Clamens, S., Besnard, S., et al. (2001). Atherosclerosis 156, 315–320.
Whitman, S. C., Ravisankar, P., and Daugherty, A. (2002). J. Interferon Cytokine Res. 22, 661–670.
Ayala, C., Croft, J. B., Greenlund, K. J., et al. (2002). Stroke 33, 1197–1201
Glader, E. L., Stegmayr, B., Norrving B., et al. (2003). Stroke 34, 1970–1975.
Wyller, T. B., Sodring, K. M., Sveen, U., Ljunggren, A. E., and Bautz-Holter, E. (1997). Clin. Rehabil. 11, 171–179.
Ladecola, C. and Alexander, M. (2001). Curr. Opin. Neurol. 14, 89–94.
del Zoppo, G., Ginis, I., Hallenbeck, J. M., Iadecola, C., Wang, X., and Feuerstein, G. Z. (2000). Brain Pathol. 10, 92–112.
Zheng, Z. and Yenari, M. A. (2004). Neurol. Res. 26, 884–892.
Zhai, Q. H., Futrell, N., and Chen, F. J. (1997). J. Neurol. Sci. 152, 119–124.
Buttini, M., Appel, K., Sauter, A., Gebicke-Haerter, P. J., and Boddeke, H. W. (1996). Neuroscience 71, 1–16.
Li, H. L., Kostulas, N., Huang, Y. M., et al. (2001). J. Neuroimmunol. 116, 5–14.
Wang, X., Yue, T. I., Young, P. R., Barone, F. C., and Feuerstein, G. Z. (1995). J. Cereb. Blood Flow. Metab. 15, 166–171.
Hill, J. K., Gunion-Rinker, L., Kulhanek, D., et al. (1999) Brain Res. 820, 45–54.
Barone, F. C., Arvin, B., White, R. F., et al. (1997). Stroke 28, 1233–1244.
Yamasaki, Y., Matsuura, N., Shozuhara, H., Onodera, H., Itoyama, Y., and Kogure, K. (1995). Stroke, 26, 676–681.
Mulcahy, N. J., Ross, J., and Rothwell, N. J. (2003). Br. J. Pharmacol. 140, 471–476
Relton, J. K., Martin, D., Thompson, R. C., and Russel, D. A. (1996). Exp. Neurol. 138, 206–213.
Nawashiro, H., Martin, D., and Hallenbeck, J. M. (1997). J. Cereb. Blood Flow. Metab. 17, 229–232.
Martin-Villalba, A., Hahne, M., Kleber, S., et al. (2001). Cell. Death Differ. 8, 679–686.
Yang, G. Y., Gong, C., Qin, Z., Ye, W., Mao, Y., and Bertz, A. L. (1998). Neuroreport 9, 2131–2134.
Dawson, D. A., Martin, D., and Hallenbeck, J. M. (1996). Neurosci. Lett. 218, 41–44.
Loddick, S. A. and Rothwell, N. J. (1996). J. Cereb. Blood. Flow Metab. 16, 932–940.
Martin, D., Chinookoswong, N., and Miller, G., (1994). Exp. Neurol. 130, 362–367.
Vila, N., Castillo, J., Davalos, A., and Chamorro, A. (2000). Stroke 31, 2325–2329.
Vila, N., Reverter, J. C., Yague, J., and Chamorro, A. (2000). J. Interferon. Cytokine Res. 20, 325–329.
Zaremba, J., and Losy, J. (2002) Acta Neurol. Scand. 104, 288–295.
Kim, H. M., Shin, H. Y., Jeong, H. J., et al. (2000). J. Mol. Neurosci. 14, 191–196.
Grau, A. J., Reis, A., and Buggle, F (2001). J. Neurol. Sci. 15, 41–47.
Smith, C. J., Emsley, H. C., Gavin, C. M., et al. (2004). BMC Neurol., 4, 2–9.
Su-Lan, L., Wen-Yin, Ch., and Chun-Jung, Ch. (2002). Neurosci. Lett. 330, 159–162.
Ospina, J. A., Brevig, H. N., Krause, D. N., and Duckles, S. P. (2004). Am. J. Physiol. Heart Circ. Physiol. 286, H2010-H2019.
Nogawa, S., Zhang, F., Ross, M. E., and Iadecola, C. (1997). J. Neurosci. 17, 2746–2755.
Terry, C. F., Loukaci, V., and Green, F. R. (2000). J. Biol. Chem. 275, 18138–18144.
Olivieri, F., Bonafe, M., Cavallone, L., et al. (2002). Exp. Gerontol. 37, 309–314.
Gromadzka, G., Sarzynska-Dlugosz, I., Ciesielska, A., and Członkowska, A. (2002). Eur. J. Neurol. 9(Suppl. 2), 25.
Bonafe, M., Olivieri, F., Cavallone, L., et al. (2001). Eur. J. Immunol., 31, 2357–2361.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Członkowska, A., Ciesielska, A., Gromadzka, G. et al. Gender differences in neurological disease. Endocr 29, 243–256 (2006). https://doi.org/10.1385/ENDO:29:2:243
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:29:2:243